The latest immunotherapy news and developments
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…